GlassScriptPhysician profile
Birendra Bhattarai
NPI 1851592802
$4,526.07
in general payments reported to CMS, 2019-2025
39 companies · $584 in 2025
The $584 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $676 · 2020: $228 · 2021: $840 · 2022: $925 · 2023: $681 · 2024: $591 · 2025: $584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,857.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $564.49 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $520.55 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Baxter Healthcare | $399.42 | 2022-2023 | Hillrom - Carnation Ambulatory Monitor |
| Novartis Pharmaceuticals Corporation | $324.23 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $278.63 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Astellas Pharma US INC | $245.42 | 2019-2023 | Myrbetriq |
| Phathom Pharmaceuticals, INC. | $231.20 | 2024-2025 | Voquezna |
| Abbvie INC. | $202.42 | 2021-2024 | Ubrelvy |
| Welch Allyn | $164.92 | 2021 | |
| Pfizer INC. | $154.32 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $139.75 | 2023-2025 | Gemtesa |
| Exact Sciences Corporation | $139.48 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Janssen Pharmaceuticals, INC | $122.45 | 2019-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $120.66 | 2022-2025 | Verquvo, Belsomra, Capvaxive |
| Esperion Therapeutics, INC. | $108.59 | 2020-2023 | Nexletol |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Birendra Bhattarai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.